Shares in Senseonics (NYSE:SENS) fell today even though the medical technology company beat expectations on Wall Street with its third quarter results.
The Germantown, Md.-based company posted a loss of -$17.4 million on sales of $2.1 million for the 3 months ended Sept. 30.
Get the full story at our sister site, Drug Delivery Business News.
The post Senseonics tops sales estimates with Q3 results appeared first on MassDevice.
from MassDevice http://ift.tt/2z5bYj3
Cap comentari:
Publica un comentari a l'entrada